For citations:
Shestakova E.A. Second line therapy in type 2 diabetes: legacy effect activation. Diabetes mellitus. 2017;20(5):356-362. (In Russ.) https://doi.org/10.14341/DM8793
Views PDF (Rus): 108
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
